The business case for clinical governance
As the COVID-19 pandemic continues to cast a shadow over the health of the world, we continue to learn about clinical governance at scale. We have previously drawn analogies to Australian government responses with clinical governance principles - however the parallels don’t stop there. Across the world, the economic impact of the pandemic has been palpable and is illustrative of the co-dependent relationship between health and money, where better health outcomes are known to correlate with better economic outcomes.
Sign in to continue reading
This page requires an active AICG membership, please login below to continue reading. If you are not an AICG member you can register below.
Not a member? Register now
AICG Membership provides access to exclusive resources and articles as well as free registration to select events.
Become part of a community that is committed to improving safety and quality across health and care sectors.